8-K - Summit Therapeutics Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On November 7, 2025, Summit Therapeutics Inc. (the “Company”) issued a press release noting that its partner, Akeso, Inc., (“Akeso”) published res

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 7, 2025 104 Cover Page Interactive Data File (embe

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1